Amplitude Vascular Systems (AVS), now part of Stryker (NYSE:SYK), today announced the first patient enrolled in a new study of its IVL technology. Stryker completed its acquisition of AVS, worth up to $835 million, earlier this month. The company develops intravascular lithotripsy (IVL) technology for treating severely calcified arterial … [Read more...] about Stryker enrolls first patient in first-in-human study of AVS IVL in a coronary indication
stryker
Stryker completes acquisition of Amplitude Vascular Systems
Stryker (NYSE:SYK) announced today that it completed its acquisition of Amplitude Vascular Systems (AVS) for an undisclosed amount. AVS develops an intravascular lithotripsy (IVL) platform designed to treat calcified peripheral arterial disease (PAD). It uses pulsed CO₂-generated pressure waves delivered uniformly through an IVL balloon … [Read more...] about Stryker completes acquisition of Amplitude Vascular Systems
Stryker makes IVL play with agreement to acquire Amplitude Vascular Systems
Stryker (NYSE:SYK) announced today that it entered into a definitive agreement to acquire Amplitude Vascular Systems (AVS) for an undisclosed amount. Portage, Michigan-based Stryker’s latest strategic move marks its planned entry into the intravascular lithotripsy (IVL) space. IVL remains a hot space, with Johnson & Johnson’s Shockwave … [Read more...] about Stryker makes IVL play with agreement to acquire Amplitude Vascular Systems
AHA, ACC issue guidelines for pulmonary embolism that affect Boston Scientific, Stryker
New guidelines related to pulmonary embolism could provide a boost for Boston Scientific (NYSE: BSX) and Stryker (NYSE: SYK), among others. Yesterday, the American Heart Association (AHA) and American College of Cardiology (ACC) joint committee updated its guidelines for pulmonary embolism (PE). This marks the first update since the AHA last … [Read more...] about AHA, ACC issue guidelines for pulmonary embolism that affect Boston Scientific, Stryker
Stryker’s Inari Medical launches next-gen thrombectomy system
Inari Medical — now part of Stryker — today announced the launch of its next-generation InThrill thrombectomy system. The company describes InThrill as the first and only purpose-built small vessel and arteriovenous (AV) access thrombectomy system that can deliver fast, complete luminal clot removal. Inari says its second-generation, 8-Fr, … [Read more...] about Stryker’s Inari Medical launches next-gen thrombectomy system
Stryker’s Inari Medical launches Artix thrombectomy system
Inari Medical — now part of Stryker — announced that it launched its Artix thrombectomy system for arterial thrombectomies. The company built Artix for the distinct needs of the peripheral arterial system, according to a news release. It marks Inari's inaugural entry into the arterial space. The combined aspiration plus mechanical … [Read more...] about Stryker’s Inari Medical launches Artix thrombectomy system
Stryker completes acquisition of Cerus Endovascular
Stryker (NYSE:SYK) today announced it completed the acquisition of Cerus Endovascular. The financial details of the deal were not disclosed. Cerus Endovascular designs and develops neurointerventional devices for the treatment of intracranial aneurysms. Cerus Endovascular’s CE marked products, the Contour Neurovascular system and Neqstent could … [Read more...] about Stryker completes acquisition of Cerus Endovascular
The top 10 catheter innovations of 2021
Last year was a big year for catheter innovation as medtech companies large and small received regulatory approvals for devices ranging from TAVR to single-use endoscopes. Catheter innovations weren't limited to just adults; Catheter-deployed devices for premature babies and toddlers were also approved and released. And catheter-based devices … [Read more...] about The top 10 catheter innovations of 2021
FDA clears Stryker biodegradable subacromial balloon spacer
Stryker (NYSE:SYK) this week announced that it received FDA de novo clearance for its balloon implant for arthroscopic treatment of massive irreparable rotator cuff tears. Kalamazoo, Mich.–based Stryker designed the InSpace balloon implant to restore the subacromial space without requiring sutures or fixation devices. The device has demonstrated … [Read more...] about FDA clears Stryker biodegradable subacromial balloon spacer
Stryker launches cobalt chromium flow diverter
Stryker this week said it launched its Surpass Evolve flow diverter after it received FDA approval. The flow diverter is a 64-wire cobalt-chromium device designed to re-direct blood flow and promote aneurysm healing. It follows the company's launch of Surpass Streamline in 2018. "This device builds on the success of Surpass Streamline, … [Read more...] about Stryker launches cobalt chromium flow diverter
